CRYO-CELL INTERNATIONAL, INC. Cost of Revenue
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Cost of Revenue of $1.68 million for the 3-month period ending 2026-05-31, per its 10-Q filed 2026-07-15.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-07-15
- CRYO-CELL INTERNATIONAL, INC. cost of goods and services sold for the quarter ending 2026-05-31 was $1.68M, a 9.69% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. cost of goods and services sold for the quarter ending 2026-02-28 was $1.66M, a 16.53% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. cost of goods and services sold for the quarter ending 2025-11-30 was $1.73M, a 5.95% increase year-over-year.
- CRYO-CELL INTERNATIONAL, INC. cost of goods and services sold for the quarter ending 2025-08-31 was $1.80M, a 15.26% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. cost of goods and services sold for fiscal 2025 was $7.38M, a 7.19% decline from fiscal 2024.
- CRYO-CELL INTERNATIONAL, INC. cost of goods and services sold for fiscal 2024 was $7.95M, a 5.28% decline from fiscal 2023.
- CRYO-CELL INTERNATIONAL, INC. cost of goods and services sold for fiscal 2023 was $8.39M, a 4.57% decline from fiscal 2022.
- CRYO-CELL INTERNATIONAL, INC. cost of goods and services sold for fiscal 2022 was $8.79M, a 2.20% decline from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-05-31 | $1.68M 10-Q · filed 2026-07-15 | $3.33M 10-Q · filed 2026-07-15 | $5.07M derived: sum of 3 quarters · filed 2026-07-15 | $6.87M derived: sum of 4 quarters · filed 2026-07-15 | ||
| 2026-02-28 | $1.66M 10-Q · filed 2026-04-14 | $3.39M derived: sum of 2 quarters · filed 2026-04-14 | $5.19M derived: sum of 3 quarters · filed 2026-04-14 | $7.05M derived: sum of 4 quarters · filed 2026-07-15 | ||
| 2025-11-30 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.54M derived: sum of 2 quarters · filed 2026-02-27 | $5.39M derived: sum of 3 quarters · filed 2026-07-15 | $7.38M 10-K · filed 2026-02-27 | ||
| 2025-08-31 | $1.80M 10-Q · filed 2025-10-15 | $3.66M derived: sum of 2 quarters · filed 2026-07-15 | $5.64M 10-Q · filed 2025-10-15 | $7.28M derived: sum of 4 quarters · filed 2026-07-15 | ||
| 2025-05-31 | $1.86M 10-Q · filed 2026-07-15 | $3.84M 10-Q · filed 2026-07-15 | $5.48M derived: sum of 3 quarters · filed 2026-07-15 | $7.60M derived: sum of 4 quarters · filed 2026-07-15 | ||
| 2025-02-28 | $1.98M 10-Q · filed 2026-04-14 | $3.62M derived: sum of 2 quarters · filed 2026-04-14 | $5.75M derived: sum of 3 quarters · filed 2026-04-14 | $7.77M derived: sum of 4 quarters · filed 2026-04-14 | ||
| 2024-11-30 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.76M derived: sum of 2 quarters · filed 2026-02-27 | $5.79M derived: sum of 3 quarters · filed 2026-02-27 | $7.95M 10-K · filed 2026-02-27 | ||
| 2024-08-31 | $2.13M 10-Q · filed 2025-10-15 | $4.15M derived: sum of 2 quarters · filed 2025-10-15 | $6.31M 10-Q · filed 2025-10-15 | $8.24M derived: sum of 4 quarters · filed 2025-10-15 | ||
| 2024-05-31 | $2.02M 10-Q · filed 2025-07-15 | $4.19M 10-Q · filed 2025-07-15 | $6.11M derived: sum of 3 quarters · filed 2025-07-15 | $8.27M derived: sum of 4 quarters · filed 2025-07-15 | ||
| 2024-02-29 | $2.07M 10-Q · filed 2025-04-14 | $2.16M 10-Q · filed 2024-04-15 | $4.09M derived: sum of 2 quarters · filed 2025-04-14 | $6.25M derived: sum of 3 quarters · filed 2025-04-14 | $8.39M derived: sum of 4 quarters · filed 2025-04-14 | |
| 2023-11-30 | $2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $4.18M derived: sum of 2 quarters · filed 2025-02-28 | $6.32M derived: sum of 3 quarters · filed 2025-02-28 | $8.39M 10-K · filed 2025-02-28 | $8.44M 10-K · filed 2024-02-28 | |
| 2023-08-31 | $2.16M 10-Q · filed 2024-10-15 | $4.30M derived: sum of 2 quarters · filed 2024-10-15 | $6.37M 10-Q · filed 2024-10-15 | $8.51M derived: sum of 4 quarters · filed 2024-10-15 | ||
| 2023-05-31 | $2.14M 10-Q · filed 2024-07-15 | $4.21M 10-Q · filed 2024-07-15 | $6.35M derived: sum of 3 quarters · filed 2024-07-15 | $8.70M derived: sum of 4 quarters · filed 2024-07-15 | ||
| 2023-02-28 | $2.07M 10-Q · filed 2024-04-15 | $4.21M derived: sum of 2 quarters · filed 2024-04-15 | $6.55M derived: sum of 3 quarters · filed 2024-04-15 | $8.76M derived: sum of 4 quarters · filed 2024-04-15 | ||
| 2022-11-30 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $4.49M derived: sum of 2 quarters · filed 2024-02-28 | $6.69M derived: sum of 3 quarters · filed 2024-02-28 | $8.79M 10-K · filed 2024-02-28 | ||
| 2022-08-31 | $2.35M 10-Q · filed 2023-10-12 | $4.55M derived: sum of 2 quarters · filed 2023-10-12 | $6.65M 10-Q · filed 2023-10-12 | $8.95M derived: sum of 4 quarters · filed 2023-10-12 | ||
| 2022-05-31 | $2.20M 10-Q · filed 2023-07-14 | $4.30M 10-Q · filed 2023-07-14 | $6.60M derived: sum of 3 quarters · filed 2023-07-14 | $9.06M derived: sum of 4 quarters · filed 2023-07-14 | ||
| 2022-02-28 | $2.10M 10-Q · filed 2023-04-21 | $4.40M derived: sum of 2 quarters · filed 2023-04-21 | $6.86M derived: sum of 3 quarters · filed 2023-04-21 | $9.08M derived: sum of 4 quarters · filed 2023-04-21 | ||
| 2021-11-30 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $4.75M derived: sum of 2 quarters · filed 2023-02-28 | $6.98M derived: sum of 3 quarters · filed 2023-02-28 | $8.99M 10-K · filed 2023-02-28 | ||
| 2021-08-31 | $2.46M 10-Q · filed 2022-10-18 | $4.68M derived: sum of 2 quarters · filed 2022-10-18 | $6.69M 10-Q · filed 2022-10-18 | $9.01M derived: sum of 4 quarters · filed 2022-10-18 | ||
| 2021-05-31 | $2.22M 10-Q · filed 2022-07-11 | $4.23M 10-Q · filed 2022-07-11 | $6.55M derived: sum of 3 quarters · filed 2022-07-11 | $8.91M derived: sum of 4 quarters · filed 2022-07-11 | ||
| 2021-02-28 | $2.01M 10-Q · filed 2022-04-13 | $4.33M derived: sum of 2 quarters · filed 2022-04-13 | $6.69M derived: sum of 3 quarters · filed 2022-04-13 | $9.17M derived: sum of 4 quarters · filed 2022-04-13 | ||
| 2020-11-30 | $2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $4.67M derived: sum of 2 quarters · filed 2022-02-22 | $7.15M derived: sum of 3 quarters · filed 2022-02-22 | $9.66M 10-K · filed 2022-02-22 | ||
| 2020-08-31 | $2.36M 10-Q · filed 2021-10-15 | $4.84M derived: sum of 2 quarters · filed 2021-10-15 | $7.34M 10-Q · filed 2021-10-15 | $9.70M derived: sum of 4 quarters · filed 2021-10-15 | ||
| 2020-05-31 | $2.48M 10-Q · filed 2021-07-15 | $4.98M 10-Q · filed 2021-07-15 | $7.34M derived: sum of 3 quarters · filed 2021-07-15 | $9.93M derived: sum of 4 quarters · filed 2021-07-15 | ||
| 2020-02-29 | $2.50M 10-Q · filed 2021-04-14 | $4.86M derived: sum of 2 quarters · filed 2021-04-14 | $7.44M derived: sum of 3 quarters · filed 2021-04-14 | $10.07M derived: sum of 4 quarters · filed 2021-04-14 | ||
| 2019-11-30 | $2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $4.94M derived: sum of 2 quarters · filed 2021-03-01 | $7.57M derived: sum of 3 quarters · filed 2021-03-01 | $10.04M 10-K · filed 2021-03-01 | ||
| 2019-08-31 | $2.59M 10-Q · filed 2020-10-15 | $5.22M derived: sum of 2 quarters · filed 2020-10-15 | $7.68M 10-Q · filed 2020-10-15 | $10.36M derived: sum of 4 quarters · filed 2020-10-15 | ||
| 2019-05-31 | $2.63M 10-Q · filed 2020-07-10 | $5.09M 10-Q · filed 2020-07-10 | $7.77M derived: sum of 3 quarters · filed 2020-07-10 | $10.26M derived: sum of 4 quarters · filed 2020-07-10 | ||
| 2019-02-28 | $2.47M 10-Q · filed 2020-04-14 | $5.14M derived: sum of 2 quarters · filed 2020-04-14 | $7.63M derived: sum of 3 quarters · filed 2020-04-14 | $9.40M derived: sum of 4 quarters · filed 2020-04-14 | ||
| 2018-11-30 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $5.16M derived: sum of 2 quarters · filed 2020-02-28 | $6.94M derived: sum of 3 quarters · filed 2020-02-28 | $8.54M 10-K · filed 2020-02-28 | ||
| 2018-08-31 | $2.49M 10-Q · filed 2019-10-15 | $4.26M derived: sum of 2 quarters · filed 2019-10-15 | $5.86M 10-Q · filed 2019-10-15 | $7.50M derived: sum of 4 quarters · filed 2019-10-15 | ||
| 2018-05-31 | $1.78M 10-Q · filed 2019-07-15 | $3.38M 10-Q · filed 2019-07-15 | $5.02M derived: sum of 3 quarters · filed 2019-07-15 | $6.99M derived: sum of 4 quarters · filed 2019-07-15 | ||
| 2018-02-28 | $1.60M 10-Q · filed 2019-04-15 | $3.24M derived: sum of 2 quarters · filed 2019-04-15 | $5.22M derived: sum of 3 quarters · filed 2019-04-15 | |||
| 2017-11-30 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $3.62M derived: sum of 2 quarters · filed 2019-02-28 | $6.72M 10-K · filed 2019-02-28 | |||
| 2017-08-31 | $1.98M 10-Q · filed 2018-10-15 | $5.09M 10-Q · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |